Evidence map›Paper›PMID 28272447›Full record

ArticleScientific reports2017

Eggshell membrane powder ameliorates intestinal inflammation by facilitating the restitution of epithelial injury and alleviating microbial dysbiosis.

Huijuan Jia, Manaka Hanate, Wanping Aw, Hideomi Itoh, Kenji Saito, Shoko Kobayashi, Satoshi Hachimura, Shinji Fukuda, Masaru Tomita, Yukio Hasebe and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Pharmacokinetic Profiling UsingInternational journal of molecular sciences · 2025
    Article
  6. Antioxidants (Basel, Switzerland) · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Huijuan JiaCorporate Sponsored Research Program "Food for Life," Organization for Interdisciplinary Research Projects, The University of Tokyo, Tokyo, Japan.
Manaka HanateDepartment of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.
Wanping AwCorporate Sponsored Research Program "Food for Life," Organization for Interdisciplinary Research Projects, The University of Tokyo, Tokyo, Japan.
Hideomi ItohBioproduction Research Institute, National Institute of Advanced Industrial Science and Technology (AIST) Hokkaido, Sapporo, Japan.
Kenji SaitoCorporate Sponsored Research Program "Food for Life," Organization for Interdisciplinary Research Projects, The University of Tokyo, Tokyo, Japan.
Shoko KobayashiResearch Center for Food Safety, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.
Satoshi HachimuraResearch Center for Food Safety and Department of Applied Biological Chemistry, Graduate School of Agricultural and Life sciences, The University of Tokyo, Tokyo, Japan.
Shinji FukudaInstitute for Advanced Biosciences, Keio University, Yamagata, Japan.
Masaru TomitaInstitute for Advanced Biosciences, Keio University, Yamagata, Japan.
Yukio HasebeALMADO Inc., Tokyo, Japan.
Hisanori KatoCorporate Sponsored Research Program "Food for Life," Organization for Interdisciplinary Research Projects, The University of Tokyo, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gut microbiota is an essential factor in the shaping of intestinal immune system development and driving inflammation in inflammatory bowel disease (IBD). We report the effects and microbe-host interactions underlying an intervention using fine powder of eggshell membrane (ESM) against IBD. ESM attenuated lipopolysaccharide-induced inflammatory cytokine production and promoted the Caco-2 cell proliferation by up-regulating growth factors in vitro. In a murine model of dextran sodium sulphate-induced colitis, ESM significantly suppressed the disease activity index and colon shortening. These effects were associated with significant ameliorations of gene expressions of inflammatory mediators, intestinal epithelial cell proliferation, restitution-related factors and antimicrobial peptides. Multifaceted integrated omics analyses revealed improved levels of energy metabolism-related genes, proteins and metabolites. Concomitantly, cecal metagenomic information established an essential role of ESM in improving dysbiosis characterized by increasing the diversity of bacteria and decreasing absolute numbers of pathogenic bacteria such as Enterobacteriaceae and E. coli, as well as in the regulation of the expansion of Th17 cells by suppressing the overgrowth of segmented filamentous bacteria. Such modulations have functional effects on the host; i.e., repairing the epithelium, regulating energy requirements and eventually alleviating mucosal inflammation. These findings are first insights into ESM's modulation of microbiota and IBD suppression, providing new perspectives on the prevention/treatment of IBD.

Indexed as

DysbiosisAnimalsAntimicrobial Cationic PeptidesCaco-2 CellsCell ProliferationColitisDextran SulfateEgg ShellEnergy MetabolismEnterobacteriaceaeGastrointestinal MicrobiomeHumansInterleukin-6Intestinal MucosaLipopolysaccharidesMaleAntimicrobial Cationic PeptidesDextran SulfateInterleukin-6Lipopolysaccharides

Identifiers

PMID28272447
PMCPMC5341015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.